Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ganglioneuroblastoma 3Breast Neoplasms 3Neuroblastoma 2Gliosarcoma 2Glioblastoma 2Wilms Tumor 1Uterine Cervical Neoplasms 1Thyroid Neoplasms 1Thyroid Diseases 1Thyroid Cancer, Papillary 1Thoracic Diseases 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Seroma 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Parathyroid Neoplasms 1Parathyroid Diseases 1Pancreatic Neoplasms 1Ovarian Germ Cell Cancer 1Neoplasm Metastasis 1Lymphatic Metastasis 1Lung Neoplasms 1

Interventions

Irinotecan 13Cyclophosphamide 11Vincristine 10Filgrastim 10Radiotherapy 9Ifosfamide 9Doxorubicin 9Dactinomycin 7Melphalan 6Granulocyte Colony-Stimulating Factor 6Etoposide 6cixutumumab 5Sirolimus 5Peripheral Blood Stem Cell Transplantation 5pegfilgrastim 4Topotecan 4Temozolomide 4Radiation 4Gemcitabine 4Busulfan 4temsirolimus 3sargramostim 3Granulocyte-Macrophage Colony-Stimulating Factor 3Albumin-Bound Paclitaxel 3130-nm albumin-bound paclitaxel 3trioctyl phosphine oxide 2regorafenib 2olaparib 2etoposide phosphate 2eribulin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Rhabdomyosarcoma × Congresses as Topic × Clear all
NCT00075582 2021-11-19

Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
390 enrolled 14 charts
Sarcoma

Rhabdomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡